Scott Steinmetz, MD
Surgery · Bel Air, MDNPI 1780687996
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (37.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $4,404 and has fallen 91.4% since, to $377 in 2025.
Across 108 payments — averaging $115.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Davol Inc.$1K
- Johnson & Johnson$522
- W. L. Gore & Associates, Inc.$195
- Baxter Healthcare$118
- Conmed Corporation$77
- plus $182 from 8 others
What the payments were for
- Travel & lodging$3,18426%
- Food & beverage$4,52336%
- Education$4,71138%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 61 | $9,860 |
| Davol Inc. | 18 | $1,478 |
| Johnson & Johnson | 16 | $522 |
| W. L. Gore & Associates, Inc. | 2 | $195 |
| Baxter Healthcare | 1 | $118 |
| Conmed Corporation | 1 | $77 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Biocomposites Inc | 1 | $30 |
| Vertex | 1 | $23 |
| Abbott | 1 | $22 |
| Stryker | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $18 |
| Covidien LP | 1 | $14 |
| Medela LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,011
- DAVINCI XI$1,000
- Phasix Mesh$597
- VENTRALIGHT$143
- PROGEL$129
- SYNECOR Biomaterial$119
- FLOSEAL$118
- Enseal X1$101
How this compares
$12,431 in reported general payments places this provider in the 85th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 101 | $250 |
| Neomycin Sulfate | 35 | $183 |
| Metronidazole | 42 | $109 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other surgery in Bel Air
- Geoffrey BloomfieldBel Air$14K
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- Adrian ParkHagerstown$355K
- Igor BelyanskyAnnapolis$339K
- John LedonneBaltimore$329K
- Emad KandilOwings Mills$247K
- Martin MakaryBaltimore$135K
- Richard LuAnnapolis$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.